Neurons use chemical 'chords' to shape signalingFebruary 28, 2008Researchers have discovered that neurons can use two different neurotransmitters that target the same receptor on a receiving neuron to shape the transmission of a nerve impulse. Although the researchers' experiments identified the "co-release" of the two neurotransmitters only in specific types of neurons in the brain's auditory center, their finding may apply more broadly in the brain, they said. Thus, the finding may represent a new way in which the brain precisely modulates the nerve impulses that travel from neuron to neuron in its circuitry. Tao Lu and colleagues Maria Rubio and Laurence Trussell reported their findings in the February 28, 2008, issue of the journal Neuron, published by Cell Press. To propagate a nerve impulse within neural circuitry, one neuron launches a burst of chemical signal called a neurotransmitter at a receiving neuron, where the neurotransmitter attaches to a specific receptor-like a key fitting a lock. That neurotransmitter-specific receptor is activated to trigger a nerve impulse in the receiving neuron. Such nerve impulses, however, rather than being the electrical equivalent of a shotgun blast, are precisely modulated signals, like the finely shaped notes of an orchestra. In studies over the past several decades, researchers had found evidence for co-release of different neurotransmitters by the same neuron. But they had assumed that in such cotransmission, each neurotransmitter targeted its own receptor on the receiving neuron. However, Lu and colleagues performed biochemical and electrophysiological experiments on rat neurons and established that two neurotransmitters-called GABA and glycine-both target the glycine receptor in specific types of neurons. The neurons they studied reside in the part of the rat auditory system that processes sound location. Thus, shaping the timing of the nerve impulse is important for such processing. Glycine acts as an inhibitory neurotransmitter in such neurons, and Lu and colleagues found that GABA acts on the glycine receptor to accelerate glycine-produced inhibition. Lu and colleagues wrote that, although their studies only establish the role of GABA/glycine cotransmission in the specialized auditory neurons, other studies had found evidence for cotransmission in other areas of the brain. Such findings hint that the two neurotransmitters may work in concert elsewhere "at a single receptor to enhance the temporal resolution of inhibition." "Of course, a hallmark of a great scientific study is the ability to approach an established problem from a fresh perspective," wrote Joshua Singer in a preview of the article in the same issue of Neuron. "And certainly the present work by Lu, Rubio, and Trussell characterizes this." Singer, who is at Northwestern University, asked, "Who would have thought that GABA [is a natural trigger for glycine receptors]" Not me, unfortunately." Cell Press |
|||||||||||||||||||||
| Related Neurotransmitter Current Events and Neurotransmitter News Articles Researchers begin to decipher metabolism of sexual assault drug It's a naturally occurring brain chemical with an unwieldy name: 4-hydroxybutyrate (4-HB). Taken by mouth, it can be abused or used as a date-rape drug. New Down syndrome treatment suggested by Stanford/Packard study in mice At birth, children with Down syndrome aren't developmentally delayed. But as they age, these kids fall behind. Memory deficits inherent in Down syndrome hinder learning, making it hard for the brain to collect experiences needed for normal cognitive development. Cognitive dysfunction reversed in mouse model of Down syndrome A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down's syndrome. CSHL team solves structure of NMDA receptor unit that could be drug target for neurological diseases A team of scientists at Cold Spring Harbor Laboratory (CSHL) reports on Thursday their success in solving the molecular structure of a key portion of a cellular receptor implicated in Alzheimer's, Parkinson's, and other serious illnesses. Mood improves on low-fat, but not low-carb, diet plan After one year, a low-calorie, low-fat diet appears more beneficial to dieters' mood than a low-carbohydrate plan with the same number of calories. BUSM researchers show dieters can experience neurobiological similarities of drug addicts Researchers from Boston University School of Medicine (BUSM) have shown that intermittent access to foods rich in fat and sugar induces changes in the brain which are comparable to those observed in drug dependence. Scripps team shows diet switching can activate brain's stress system, lead to 'withdrawal' symptoms In research that sheds light on the perils of yo-yo dieting and repeated bouts of sugar-bingeing, researchers from The Scripps Research Institute have shown in animal models that cycling between periods of eating sweet and regular-tasting food can activate the brain's stress system and generate overeating, anxiety, and withdrawal-like symptoms. Widely used cholesterol-lowering drug may prevent progression Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease. Benefit of memantine in the treatment of Alzheimer's disease not proven There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. Changes in brain chemicals mark shifts in infant learning When do you first leave the nest? Early in development infants of many species experience important transitions-such as learning when to leave the protective presence of their mother to start exploring the wider world. More Neurotransmitter Current Events and Neurotransmitter News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||